Compare ELME & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELME | OSUR |
|---|---|---|
| Founded | 1960 | 2000 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 174.3M |
| IPO Year | N/A | N/A |
| Metric | ELME | OSUR |
|---|---|---|
| Price | $2.17 | $2.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $14.25 | $3.00 |
| AVG Volume (30 Days) | ★ 5.6M | 488.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 33.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $2.08 |
| 52 Week High | $17.68 | $4.22 |
| Indicator | ELME | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 8.35 | 52.70 |
| Support Level | $2.15 | $2.72 |
| Resistance Level | $2.26 | $2.90 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | 0.51 | -0.01 |
| Stochastic Oscillator | 46.88 | 33.94 |
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.